Comparación de niveles de enzimas antioxidantes en una cohorte de pacientes pediátricos con y sin sarcomas.

Saved in:
Bibliographic Details
Title: Comparación de niveles de enzimas antioxidantes en una cohorte de pacientes pediátricos con y sin sarcomas.
Alternate Title: Comparison of Antioxidant Enzyme Levels in a Pediatric Cohort with and Without Sarcomas.
Authors: Correa Carranza, Valeria1 valcorcar@gmail.com, Rosario Méndez, Guillermo2, Maldonado Salinas, Rebeca3, De Jesús Castillejos López, Manuel4, Moncada Morales, Angélica5, Márquez García, Eduardo5, García Guzmán, Alda Daniela6, Velasco Hidalgo, Liliana7, Cárdenas Cardos, Rocío7, Sánchez Mendoza, María Elena8, Chávez Pacheco, Juan Luis9, Aquino Gálvez, Arnoldo10, Torres Espíndola, Luz María9
Source: Acta Pediatrica de Mexico. 2025 Supplement, Vol. 46, pS24-S25. 2p.
Subjects: END of treatment, MANN Whitney U Test, GLUTATHIONE reductase, CANCER treatment, GLUTATHIONE peroxidase
Abstract (English): INTRODUCTION: Oxidative stress plays a significant role in tumor progression and the response to treatment. Antioxidant enzymes, including glutathione peroxidase (GPx) and glutathione reductase (GR), help protect cells from oxidative damage. Changes in the activity of these enzymes may be linked to clinical outcomes in pediatric patients with sarcomas. OBJECTIVE: This study compared levels of GPx and GR in children with sarcomas to a control group without sarcomas. METHODOLOGY: An analytical observational study involved 30 children diagnosed with sarcomas and 43 children without sarcomas. All participants provided blood samples for plasma analysis, and a second sample was collected at the end of treatment for the sarcoma group. The concentrations of GPx and GR were measured using commercial kits from Enzo and BioAssay Systems. For the statistical analysis, medians, interquartile ranges, and the Mann-Whitney U test were utilized. RESULTS: Initial levels of GPx were found to be higher in children diagnosed with sarcomas, with a median of 164.4 U/mL ([Q25 114.9–Q75 188.85]), compared to the control group, which had a median of 108.83 U/mL (Q25 93.96–Q75 137.77; p < 0.05). After treatment, the final levels of GR were lower in the children with sarcomas, measuring 3.79 U/L (Q25 3.14–Q75 5.04), in contrast to the control group, which showed levels of 4.77 U/L (Q25 3.82–Q75 5.45; p < 0.05). CONCLUSIONS: Sarcomas and their treatment can induce changes in cellular redox status, particularly by initially activating GPx and decreasing the final activity of GR. These alterations could influence the prognosis of pediatric patients with sarcomas. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): INTRODUCCIÓN: El estrés oxidativo está implicado en la progresión tumoral y respuesta al tratamiento. Las enzimas antioxidantes, como glutatión peroxidasa (GPx) y glutatión reductasa (GR), defienden a la célula de este daño oxidativo. En pacientes pediátricos con sarcomas, su actividad podría estar alterada y asociarse a la evolución clínica. OBJETIVO: Comparar los niveles de GPx y GR entre niños con sarcomas y un grupo control sin sarcomas. METODOLOGÍA: Estudio observacional analítico con 30 niños con sarcomas y 43 sin sarcomas. A todos se les obtuvo una muestra sanguínea para análisis plasmático; en los pacientes con sarcomas se tomó una segunda muestra al finalizar el tratamiento. Las concentraciones de GPx y GR se determinaron mediante kits comerciales (Enzo y BioAssay Systems). Se utilizaron medianas, rangos intercuartílicos y U de MannWhitney para análisis estadístico. RESULTADOS: Los niveles iniciales de GPx fueron mayores en niños con sarcomas (mediana 164.4 U/mL, Q25 114.9–Q75 188.85) que en el grupo control (108.83 U/ mL, Q25 93.96–Q75 137.77; p < 0.05). Después del tratamiento, los niveles finales de GR fueron menores en los niños con sarcomas, midiendo 3,79 U/L (Q25 3,14–Q75 5,04), en contraste con el grupo control, que mostró niveles de 4,77 U/L (Q25 3,82– Q75 5,45; p < 0,05). CONCLUSIONES: Los sarcomas y su tratamiento podrían inducir alteraciones en el estado redox celular, particularmente una activación inicial de GPx y disminución de la actividad final de GR, lo cual podría influir en el pronóstico de los pacientes pediátricos con sarcomas. [ABSTRACT FROM AUTHOR]
Copyright of Acta Pediatrica de Mexico is the property of Instituto Nacional de Pediatria (INP) and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: lth
DbLabel: MedicLatina
An: 186821876
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparaci&#243;n de niveles de enzimas antioxidantes en una cohorte de pacientes pedi&#225;tricos con y sin sarcomas.
– Name: TitleAlt
  Label: Alternate Title
  Group: TiAlt
  Data: Comparison of Antioxidant Enzyme Levels in a Pediatric Cohort with and Without Sarcomas.
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Correa+Carranza%2C+Valeria%22&quot;&gt;Correa Carranza, Valeria&lt;/searchLink&gt;&lt;relatesTo&gt;1&lt;/relatesTo&gt;&lt;i&gt; valcorcar@gmail.com&lt;/i&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Rosario+M&#233;ndez%2C+Guillermo%22&quot;&gt;Rosario M&#233;ndez, Guillermo&lt;/searchLink&gt;&lt;relatesTo&gt;2&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Maldonado+Salinas%2C+Rebeca%22&quot;&gt;Maldonado Salinas, Rebeca&lt;/searchLink&gt;&lt;relatesTo&gt;3&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22De+Jes&#250;s+Castillejos+L&#243;pez%2C+Manuel%22&quot;&gt;De Jes&#250;s Castillejos L&#243;pez, Manuel&lt;/searchLink&gt;&lt;relatesTo&gt;4&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Moncada+Morales%2C+Ang&#233;lica%22&quot;&gt;Moncada Morales, Ang&#233;lica&lt;/searchLink&gt;&lt;relatesTo&gt;5&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22M&#225;rquez+Garc&#237;a%2C+Eduardo%22&quot;&gt;M&#225;rquez Garc&#237;a, Eduardo&lt;/searchLink&gt;&lt;relatesTo&gt;5&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Garc&#237;a+Guzm&#225;n%2C+Alda+Daniela%22&quot;&gt;Garc&#237;a Guzm&#225;n, Alda Daniela&lt;/searchLink&gt;&lt;relatesTo&gt;6&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Velasco+Hidalgo%2C+Liliana%22&quot;&gt;Velasco Hidalgo, Liliana&lt;/searchLink&gt;&lt;relatesTo&gt;7&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22C&#225;rdenas+Cardos%2C+Roc&#237;o%22&quot;&gt;C&#225;rdenas Cardos, Roc&#237;o&lt;/searchLink&gt;&lt;relatesTo&gt;7&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22S&#225;nchez+Mendoza%2C+Mar&#237;a+Elena%22&quot;&gt;S&#225;nchez Mendoza, Mar&#237;a Elena&lt;/searchLink&gt;&lt;relatesTo&gt;8&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Ch&#225;vez+Pacheco%2C+Juan+Luis%22&quot;&gt;Ch&#225;vez Pacheco, Juan Luis&lt;/searchLink&gt;&lt;relatesTo&gt;9&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Aquino+G&#225;lvez%2C+Arnoldo%22&quot;&gt;Aquino G&#225;lvez, Arnoldo&lt;/searchLink&gt;&lt;relatesTo&gt;10&lt;/relatesTo&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Torres+Esp&#237;ndola%2C+Luz+Mar&#237;a%22&quot;&gt;Torres Esp&#237;ndola, Luz Mar&#237;a&lt;/searchLink&gt;&lt;relatesTo&gt;9&lt;/relatesTo&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: &lt;searchLink fieldCode=&quot;JN&quot; term=&quot;%22Acta+Pediatrica+de+Mexico%22&quot;&gt;Acta Pediatrica de Mexico&lt;/searchLink&gt;. 2025 Supplement, Vol. 46, pS24-S25. 2p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22END+of+treatment%22&quot;&gt;END of treatment&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22MANN+Whitney+U+Test%22&quot;&gt;MANN Whitney U Test&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22GLUTATHIONE+reductase%22&quot;&gt;GLUTATHIONE reductase&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22CANCER+treatment%22&quot;&gt;CANCER treatment&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22GLUTATHIONE+peroxidase%22&quot;&gt;GLUTATHIONE peroxidase&lt;/searchLink&gt;
– Name: Abstract
  Label: Abstract (English)
  Group: Ab
  Data: INTRODUCTION: Oxidative stress plays a significant role in tumor progression and the response to treatment. Antioxidant enzymes, including glutathione peroxidase (GPx) and glutathione reductase (GR), help protect cells from oxidative damage. Changes in the activity of these enzymes may be linked to clinical outcomes in pediatric patients with sarcomas. OBJECTIVE: This study compared levels of GPx and GR in children with sarcomas to a control group without sarcomas. METHODOLOGY: An analytical observational study involved 30 children diagnosed with sarcomas and 43 children without sarcomas. All participants provided blood samples for plasma analysis, and a second sample was collected at the end of treatment for the sarcoma group. The concentrations of GPx and GR were measured using commercial kits from Enzo and BioAssay Systems. For the statistical analysis, medians, interquartile ranges, and the Mann-Whitney U test were utilized. RESULTS: Initial levels of GPx were found to be higher in children diagnosed with sarcomas, with a median of 164.4 U/mL ([Q25 114.9–Q75 188.85]), compared to the control group, which had a median of 108.83 U/mL (Q25 93.96–Q75 137.77; p &lt; 0.05). After treatment, the final levels of GR were lower in the children with sarcomas, measuring 3.79 U/L (Q25 3.14–Q75 5.04), in contrast to the control group, which showed levels of 4.77 U/L (Q25 3.82–Q75 5.45; p &lt; 0.05). CONCLUSIONS: Sarcomas and their treatment can induce changes in cellular redox status, particularly by initially activating GPx and decreasing the final activity of GR. These alterations could influence the prognosis of pediatric patients with sarcomas. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label: Abstract (Spanish)
  Group: Ab
  Data: INTRODUCCI&#211;N: El estr&#233;s oxidativo est&#225; implicado en la progresi&#243;n tumoral y respuesta al tratamiento. Las enzimas antioxidantes, como glutati&#243;n peroxidasa (GPx) y glutati&#243;n reductasa (GR), defienden a la c&#233;lula de este da&#241;o oxidativo. En pacientes pedi&#225;tricos con sarcomas, su actividad podr&#237;a estar alterada y asociarse a la evoluci&#243;n cl&#237;nica. OBJETIVO: Comparar los niveles de GPx y GR entre ni&#241;os con sarcomas y un grupo control sin sarcomas. METODOLOG&#205;A: Estudio observacional anal&#237;tico con 30 ni&#241;os con sarcomas y 43 sin sarcomas. A todos se les obtuvo una muestra sangu&#237;nea para an&#225;lisis plasm&#225;tico; en los pacientes con sarcomas se tom&#243; una segunda muestra al finalizar el tratamiento. Las concentraciones de GPx y GR se determinaron mediante kits comerciales (Enzo y BioAssay Systems). Se utilizaron medianas, rangos intercuart&#237;licos y U de MannWhitney para an&#225;lisis estad&#237;stico. RESULTADOS: Los niveles iniciales de GPx fueron mayores en ni&#241;os con sarcomas (mediana 164.4 U/mL, Q25 114.9–Q75 188.85) que en el grupo control (108.83 U/ mL, Q25 93.96–Q75 137.77; p &lt; 0.05). Despu&#233;s del tratamiento, los niveles finales de GR fueron menores en los ni&#241;os con sarcomas, midiendo 3,79 U/L (Q25 3,14–Q75 5,04), en contraste con el grupo control, que mostr&#243; niveles de 4,77 U/L (Q25 3,82– Q75 5,45; p &lt; 0,05). CONCLUSIONES: Los sarcomas y su tratamiento podr&#237;an inducir alteraciones en el estado redox celular, particularmente una activaci&#243;n inicial de GPx y disminuci&#243;n de la actividad final de GR, lo cual podr&#237;a influir en el pron&#243;stico de los pacientes pedi&#225;tricos con sarcomas. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: &lt;i&gt;Copyright of Acta Pediatrica de Mexico is the property of Instituto Nacional de Pediatria (INP) and its content may not be copied or emailed to multiple sites without the copyright holder&#39;s express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.&lt;/i&gt; (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=lth&AN=186821876
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: spa
        Text: Spanish
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S24
    Subjects:
      – SubjectFull: END of treatment
        Type: general
      – SubjectFull: MANN Whitney U Test
        Type: general
      – SubjectFull: GLUTATHIONE reductase
        Type: general
      – SubjectFull: CANCER treatment
        Type: general
      – SubjectFull: GLUTATHIONE peroxidase
        Type: general
    Titles:
      – TitleFull: Comparación de niveles de enzimas antioxidantes en una cohorte de pacientes pediátricos con y sin sarcomas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Correa Carranza, Valeria
      – PersonEntity:
          Name:
            NameFull: Rosario Méndez, Guillermo
      – PersonEntity:
          Name:
            NameFull: Maldonado Salinas, Rebeca
      – PersonEntity:
          Name:
            NameFull: De Jesús Castillejos López, Manuel
      – PersonEntity:
          Name:
            NameFull: Moncada Morales, Angélica
      – PersonEntity:
          Name:
            NameFull: Márquez García, Eduardo
      – PersonEntity:
          Name:
            NameFull: García Guzmán, Alda Daniela
      – PersonEntity:
          Name:
            NameFull: Velasco Hidalgo, Liliana
      – PersonEntity:
          Name:
            NameFull: Cárdenas Cardos, Rocío
      – PersonEntity:
          Name:
            NameFull: Sánchez Mendoza, María Elena
      – PersonEntity:
          Name:
            NameFull: Chávez Pacheco, Juan Luis
      – PersonEntity:
          Name:
            NameFull: Aquino Gálvez, Arnoldo
      – PersonEntity:
          Name:
            NameFull: Torres Espíndola, Luz María
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 05
              Text: 2025 Supplement
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 01862391
          Numbering:
            – Type: volume
              Value: 46
          Titles:
            – TitleFull: Acta Pediatrica de Mexico
              Type: main
ResultId 1